NRF-1 increases mitochondrial respiratory capacity, induces expression of a subset of genes governing mitochondrial activity in a cell-type specific manner (reviewed in (5) ) and enhances mitochondrial responses to the PPARγ co-activator PGC-1 (6).
NRF-1-independent mitochondrial gene expression pathways are regulated by PPARs, Sp 1 and other factors. Although mitochondrial gene function is co-dependent upon the nuclear genome and mitochondrial activity alters nuclear gene expression ("retrograde communication" (7)), the mechanism coordinating nuclear DNA synthesis, growth responses and mitochondrial synthesis is unknown.
4
The cyclin D1 gene encodes a labile growth factor-and oncogene-inducible component of the holoenzyme that phosphorylates and inactivates the retinoblastoma protein (pRb), promoting nuclear DNA synthesis (8) . Cyclin D1 -/-mouse embryo fibroblasts (MEFs) have a normal cell size and reduced DNA synthesis rates which can be rescued through introduction of cyclin D1 ((9) and data not shown). Cyclin D1 -/-mice are resistant to oncogene-induced tumors of the skin, gut and mammary gland (10, 11) .
Herein we examined the possibility that cyclin D1 may also function to regulate mitochondrial activity and thereby couple biosynthetic properties of the nucleus and mitochondria.
Results
To explore the role of cyclin D1 in mitochondrial gene function, we examined the mitochondrial size in cyclin D1 -/-and littermate wild type control animals. Mitochondrial size was increased 2-to 3-fold in proportion to cellular cytoplasm in hepatocytes (Fig. 1A-D), as well as to the mammary gland adipocyte (Fig. 1E, F) in cyclin D1 -/-mice.
MitoTracker Deep Red 633, used to stain the functioning mitochondria in living cells through a fluorescent signal that is proportional to the mitochondrial activity, showed increased mitochondrial activity in cyclin D1-deficient MEFs, hepatocytes, and bone marrow macrophages compared with cyclin D1-expressing cells from littermate control animals ( Fig. 1G ). Cyclin D1 wild-type and mutant cDNAs were further transduced by retroviral infection into cyclin D1 -/-MEFs in the MCSV-IRES-GFP vector to allow GFP sorting ( Fig. 2A) . Mitochondrial function, assessed using MitoTracker (6), was conducted one week after viral transduction. Cyclin D1 inhibited mitochondrial function 52% ( Fig. 2A ) and also induced DNA synthesis (16% to 52%). Furthermore, the pRbbinding-deficient (GH), and C-terminal deletion (N4) of cyclin D1 also repressed mitochondrial function, whereas the Cdk-binding-defective KE mutant failed to inhibit mitochondrial activity or induce DNA synthesis, indicating the kinase-associated function of cyclin D1 inhibits mitochondrial function.
Examination of the increased mitochondrial size in cyclin D1 -/-hepatocytes showed the abundance of NRF-1 protein was increased 3-fold in cyclin D1 -/-compared with wild type liver (Fig. 2B ) while the NRF-1 coactivators, P/CAF and PGC-1 were unchanged (data not shown and Fig. 2B ). Addition of 10% serum to starved cells 6 induced cyclin D1 expression, and DNA synthesis, and reduced NRF-1 (Fig. 2C) MitoTracker fluorescence 50% more in cyclin D1-deficient cells (Fig. 3C) . In vivo association of NRF-1 with cyclin D1 was demonstrated by the mammalian two-hybrid system using GAL4-cyclin D1 and VP16-NRF-1 fusion constructs in cyclin D1 -/-3T3 cells (Fig. 3D ).
Microarray analysis of cyclin D1 -/-MEFs transduced with a retroviral expression vector for cyclin D1, compared with empty vector identified 210 genes repressed by cyclin D1, 73 of which were similar and 18 identical to the putative NRF-1 site containing gene promoters (Fig. 3E ). As NRF-1 induces genes in a cell-type specific manner, we further identified NRF-1-responsive genes in MEFs by transducing cells with a retrovirus expressing NRF-1 and conducting microarray analysis. In these cells mitotracker activity was also induced 3-fold (data not shown). Of the 131 genes induced by NRF-1 (see supplemental material), 22 genes were similar to cyclin D1-repressed genes in MEFs.
As the Cdk4 binding-deficient mutant of cyclin D1 failed to repress NRF-1-mediated transcriptional activity, and since NRF-1 is phosphorylated (14), we compared GST-pRb and GST-NRF-1 as substrates of cyclin D1/Cdk4 kinase. NRF-1 was efficiently phosphorylated by cyclin D1-IP kinase (Fig. 4A ). Cyclin D1 co-transfection enhanced 32 P-orthophosphate labeled NRF-1 ( 
Discussion
The mechanisms integrating cell-cycle progression and/or exit with mitochondrial biogenesis were previously unknown (17, 18) . (24) and adipocytes (12) . Cyclin D1
antagonizes NRF-1 and mitochondrial function while inducing DNA synthesis, thereby potentially coupling biosynthetic priorities within the cell.
In this study we proposed that cyclin D1 may integrate cell-cycle progression and/or exit with mitochondrial biogenesis (Fig 5) . We do in fact demonstrate the increased abundance of cyclin D1 led to reduced mitochondrial activity. The outcome of reduced mitochondrial activity would be anticipated in order to shift glucose metabolism toward cytosolic glycolysis. Whether such a triage of substrate utilization or metabolic prioritization occurs in the presence of increased cyclin D1 abundance remains to be determined. A shift towards cytosolic glycolysis is known to occur during tumor progression and is a component of the metabolic change described by Dr. O. Warberg in 1930. Known components of the mitochondria-to-nucleus retrograde pathway include CREB, mRpL12, and aconitase, (which produces α-ketoglutarate) (25-27). In Drosophila, in which proliferation rates are partially uncoupled from growth, cyclin D1
induces cell size and Hif-1 prolyl hydroxylase (HPH) activity (25) . But in mammalian cells, HPH is not required for proliferation by cyclin D1/Cdk4, mitochondria inhibit HPH hydroxylase and cyclin D1 does not affect cell size (28, 29) . Mitochondria produce ATP (30), regulate single carbon metabolism, fatty acid metabolism and oxidative glycolysis (5) and are a potential target for cancer therapies (31) . As cyclin D1 is inhibited by differentiation and induced by oncogenes, this new function of cyclin D1 may provide a mechanism by which select oncogenes and growth factors contribute to tumor maintenance.
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Materials and Methods:
Mice
Mice homozygously deleted of the cyclin D1 gene (cyclin D1 -/-) (32) on a mixed C57Bl/6x129/SvJ background were maintained as described previously (9) . Genotyping was performed on tail genomic DNA by PCR under the following conditions: denaturing at 96°C for 1 min, followed by 30 cycles of 94°C for 30 sec, annealing at 58°C for 30 sec, extension at 72°C for 30 sec with a final extension at 72° for 5 min. The cyclin D1 specific primers were described (32).
Cell Culture
Day 5 Bone marrow macrophage (BMM) from cyclin D1 +/+ and cyclin D1 -/-mice were prepared as previously described (33) 
Plasmids, transfections and reporter assays
The expression vectors pCMV-cyclin D1, CMV-cyclin D1-KE, CMV-cyclin D1 GH, pCMV-cyclin E, pCMV-cyclin A and RSV-and CMV-Renilla luciferase reporter were previously described (35) . The human cyclin D1 mutants were derived by PCR-directed amplification using sequence-specific primers and cloned into pRC/CMV. The reporter plasmids NRF 4 -Luc (containing 4 tandem NRF-1 sites) (36), mtTFA-RC4wt/PGL3 (37), reporters with NRF-1, NRF-2, or Sp1 mutations (6) and the expression vector pSG5
NRF-1 (38) were previously described. Wild type and mutant cyclin D1 and NRF-1 cDNA fragments were inserted into the EcoRI site of the pMSCV-IRES-GFP vector to make pMSCV-IRES-GFP-cyclin D1 and pMSCV-IRES-GFP-NRF-1. DNA transfection and luciferase assays were performed as previously described (39) . Cells were transfected by Superfect Transfection reagent (Qiagen, Valencia, Ca).
The medium was changed after 5 h, and luciferase activity was determined after 24 h. At least two different plasmid preparations of each construct were used. In cotransfection experiments, a dose-response curve was determined in each experiment with 20 ng of expression vector and the promoter reporter plasmids (1 µg). Luciferase activity was normalized for transfection with Renilla luciferase reporter (Promega) as an internal control. Luciferase assays were performed at room temperature with an Autolumat LB 953 (EG&G Berthold). The -fold effect was determined by comparison to the empty expression vector cassette, and statistical analyses was performed using the Mann Whitney U-test.
Cytochemistry and electron microscopy
Liver and mammary gland from cyclin D1 wt and cyclin D1 -/-mice were removed under anesthesia. Slices (approximately 2 mm thick) were prepared by hand cutting with a razor and were immediately placed into cold fixative consisting of a mixture of 4 % paraformaldehyde and 2.5% glutaraldehyde in 0.1M cacodylate buffer, pH 7.4 for 3hrs
with continuous skaking. Non-frozen sections (~20 µm) of the aldehyde fixed tissue slices were prepared using a Lancer vibratome sectioning instrument (Polysciences, Warrington PA). Sections were tested for catalase activity using an incubating medium containing 3, 3" diaminobenzidine tetrahydrochloride (Sigma) as a substrate at pH 9.7 to visualize peroxisomes and microperoxisomes. The incubated sections were then fixed in 1% osmium tetraoxide (Polysciences), alcohol dehydrated and embedded in Epon.
Ultrathin sections (approximately 500 angstroms) were prepared using a LKB ultramicrotome (LKB, Sweden), stained with lead citrate and examined with a Philips 300 electron microscope (40) . All pictures were taken at the same magnification, i.e at 5000X. To determine mitochondrial size and number, stereology was performed according to the method of Weibel (12) . A grid of approximately 1cm squared was placed over each print photo (magnificatoin of 13,500X) and mitochondria within the grid were counted.
FACS analysis
Bone marrow macrophages, hepatocytes, and MEFs derived from cyclin D1 +/+ and cyclin 
D1
Retroviral infection and FACS sorting
Retroviruses were prepared as described previously (32) . Briefly, pMSCV-IRES-GFP was co-transfected with an ecotropic, replication-defective helper virus pSV- 
High Density Array Expression Analysis
Total RNA was isolated from retrovirus vector infected MEFs (infected with either MSCV-IRES-GFP vector or MSCV-IRES-FLAG-NRF-1) using Trizol. Total RNA was used to probe an Affymetrix GeneChip® Mouse Expression Set 430 array (Affymetrix, Santa Clara, CA). RNA quality was determined by gel electrophoresis. Probe synthesis and hybridization was performed according to the manufacturer's protocol (see eukaryotic target preparation section at http://www.affymetrix.com/support). Three arrays were used for each condition. Analysis of the arrays was performed as described (41) .
In vivo labeling
293T cells were plated 24 h before transfection. Prior to transfection, cells were washed incubated with phosphate-free DMEM medium for 2 h, and then 32 P-orthophosphate was added to the cell culture medium at 1 mCi/ml. Lysates were prepared and precipitated with M2 antibody for at least 6 h. Beads were washed with 6 changes of lysis buffer and protein-bound beads were denatured in SDS buffer. Protein was resolved by SDS-PAGE electrophoresis. Gels were dried and subjected to autoradiography. mechanisms regulating mitochondrial activity remain to be defined.
